{"id":20018,"date":"2025-03-16T11:07:48","date_gmt":"2025-03-16T08:07:48","guid":{"rendered":"https:\/\/kibrisayna.com\/index.php\/2025\/03\/16\/kanserde-mucadelede-yeni-gelisme-covid-asilarindan-ilham-alindi\/"},"modified":"2025-03-16T11:07:48","modified_gmt":"2025-03-16T08:07:48","slug":"kanserde-mucadelede-yeni-gelisme-covid-asilarindan-ilham-alindi","status":"publish","type":"post","link":"https:\/\/kibrisayna.com\/index.php\/2025\/03\/16\/kanserde-mucadelede-yeni-gelisme-covid-asilarindan-ilham-alindi\/","title":{"rendered":"Kanserde m\u00fccadelede yeni geli\u015fme: Covid a\u015f\u0131lar\u0131ndan ilham al\u0131nd\u0131"},"content":{"rendered":"<p> <br \/>\n<br \/><img decoding=\"async\" src=\"https:\/\/cdn1.ntv.com.tr\/gorsel\/9pVZgAkOdU-NYafhpvSvPA.jpg?width=1200&amp;ampmode=crop&amp;ampscale=both\" class=\"type:primaryImage\" alt=\"Kanserde m\u00fccadelede yeni geli\u015fme: Covid a\u015f\u0131lar\u0131ndan ilham al\u0131nd\u0131\" \/><\/p>\n<p>COVID-19 pandemisinin en \u00f6nemli teknolojik kazan\u0131mlar\u0131ndan biri olan mRNA a\u015f\u0131lar\u0131, \u015fimdi de kanserle m\u00fccadelede devrim yaratma potansiyeliyle g\u00fcndemde. COVID-19 a\u015f\u0131lar\u0131yla d\u00fcnyan\u0131n dikkatini \u00e7eken bu teknoloji, ba\u011f\u0131\u015f\u0131kl\u0131k sistemini e\u011fiterek hastal\u0131klarla daha etkili bir \u015fekilde sava\u015fmay\u0131 m\u00fcmk\u00fcn k\u0131l\u0131yor.<\/p>\n<section class=\"type:slideshow\">\n<figure><img decoding=\"async\" src=\"https:\/\/cdn1.ntv.com.tr\/gorsel\/2TcKvdo3zUm0pKm9pbmeYw.jpg?width=1200&amp;mode=crop&amp;scale=both\" width=\"1200\" \/><figcaption>mRNA kanser a\u015f\u0131lar\u0131, v\u00fccudun ba\u011f\u0131\u015f\u0131kl\u0131k sistemine belirli kanser t\u00fcrlerini hedef alma ve yok etme &#8220;talimatlar\u0131n\u0131&#8221; veriyor. Bu a\u015f\u0131lar, hastan\u0131n kanserli dokusundan al\u0131nan biyopsilerle ki\u015fiselle\u015ftiriliyor. Genetik analizlerin ard\u0131ndan, her bir hastan\u0131n kanserine \u00f6zg\u00fc bir tedavi haz\u0131rlan\u0131yor.<\/figcaption><\/figure>\n<figure><img decoding=\"async\" src=\"https:\/\/cdn1.ntv.com.tr\/gorsel\/F6X2MU5hCUWK9pnGlXft3w.jpg?width=1200&amp;mode=crop&amp;scale=both\" width=\"1200\" \/><figcaption>mRNA A\u015eISI NED\u0130R? GELENEKSEL A\u015eIDAN FARKLARI NELERD\u0130R? Mesajc\u0131 RNA (mRNA) a\u015f\u0131lar\u0131, v\u00fccudun ba\u011f\u0131\u015f\u0131kl\u0131k sistemini belirli bir protein hakk\u0131nda \u201ce\u011fitmek\u201d i\u00e7in geli\u015ftirilmi\u015f yenilik\u00e7i bir a\u015f\u0131 t\u00fcr\u00fcd\u00fcr. Geleneksel a\u015f\u0131lar\u0131n aksine, burada do\u011frudan bir patojen par\u00e7as\u0131 (\u00f6rne\u011fin protein) verilmez; bunun yerine, o proteinin nas\u0131l \u00fcretilece\u011fini anlatan mesajc\u0131 RNA (mRNA) molek\u00fcl\u00fc kullan\u0131l\u0131r. mRNA a\u015f\u0131lar\u0131 canl\u0131 patojen i\u00e7ermez, bu nedenle enfeksiyon riski ta\u015f\u0131maz. Ayr\u0131ca sitoplazmada kal\u0131r ve \u00e7ekirdekle etkile\u015fime girmezler. Bu da genetik b\u00fct\u00fcnl\u00fc\u011f\u00fc korur. Sentez s\u00fcreci h\u00fccre d\u0131\u015f\u0131 olarak ger\u00e7ekle\u015fti\u011fi i\u00e7in, mRNA a\u015f\u0131lar\u0131 geleneksel a\u015f\u0131 \u00fcretimine g\u00f6re \u00e7ok daha k\u0131sa s\u00fcrede tasarlan\u0131p \u00fcretilebilir. Bu \u00f6zellik, \u00f6zellikle pandemi gibi acil durumlarda b\u00fcy\u00fck bir avantaj sa\u011flar. \u00d6zellikle kanser a\u015f\u0131lar\u0131nda, hastaya \u00f6zg\u00fc antijen dizileri kullan\u0131larak bireyselle\u015ftirilmi\u015f tedavi yakla\u015f\u0131mlar\u0131 geli\u015ftirilebilir.<\/figcaption><\/figure>\n<figure><img decoding=\"async\" src=\"https:\/\/cdn1.ntv.com.tr\/gorsel\/EDtCZsvfKEKcTBKaLUrDLw.jpg?width=1200&amp;mode=crop&amp;scale=both\" width=\"1200\" \/><figcaption>T\u00fcm d\u00fcnyada kanser a\u015f\u0131s\u0131 i\u00e7in \u00e7al\u0131\u015fmalar olsa da bu alanda \u00f6nc\u00fcl\u00fc\u011f\u00fc \u0130ngiltere yap\u0131yor. \u00dclkede ba\u015flat\u0131lan &#8220;Kanser A\u015f\u0131lar\u0131 Ba\u015flang\u0131\u00e7 Platformu,&#8221; hem ulusal hem de uluslararas\u0131 d\u00fczeyde klinik denemelerin h\u0131zla y\u00fcr\u00fct\u00fclmesini sa\u011fl\u0131yor. Bunun yan\u0131 s\u0131ra \u0130ngiliz h\u00fckumeti, BioNTech ve Moderna gibi \u015firketlerle uzun vadeli ortakl\u0131klar kurarak, kanser tedavisi i\u00e7in \u00f6nemli yat\u0131r\u0131mlar yapt\u0131.<\/figcaption><\/figure>\n<figure><img decoding=\"async\" src=\"https:\/\/cdn1.ntv.com.tr\/gorsel\/Jd5tX1dfZUKObPnGoH1UFQ.jpg?width=1200&amp;mode=crop&amp;scale=both\" width=\"1200\" \/><figcaption>\u0130ngiltere h\u00fckumetine mRNA kanser a\u015f\u0131s\u0131 alan\u0131nda dan\u0131\u015fmanl\u0131k yapan Onkolojist Lennard Lee, \u00fclkede devam eden 15 kanser a\u015f\u0131s\u0131 denemesi oldu\u011funu s\u00f6ylerken, 2026 y\u0131l\u0131n\u0131n ilk aylar\u0131nda sonu\u00e7 almay\u0131 umduklar\u0131n\u0131 aktard\u0131. Lee, Wired\u2019a verdi\u011fi r\u00f6portajda \u201cBa\u015far\u0131l\u0131 olursa, COVID i\u00e7in ilk lisansl\u0131 mRNA a\u015f\u0131s\u0131ndan sadece 5 y\u0131l sonra, ilk onayl\u0131 ki\u015fiselle\u015ftirilmi\u015f mRNA kanser a\u015f\u0131s\u0131n\u0131 icat etmi\u015f olaca\u011f\u0131z. Bu olduk\u00e7a etkileyici\u201d ifadelerini kulland\u0131.<\/figcaption><\/figure>\n<figure><img decoding=\"async\" src=\"https:\/\/cdn1.ntv.com.tr\/gorsel\/weboG30MOEqu5DKD5YDyAQ.jpg?width=1200&amp;mode=crop&amp;scale=both\" width=\"1200\" \/><figcaption>\u015eu anda d\u00fcnya genelinde y\u00fczlerce mRNA kanser a\u015f\u0131s\u0131 denemesi devam ediyor. \u0130lk onayl\u0131 mRNA kanser a\u015f\u0131s\u0131n\u0131n \u00f6n\u00fcm\u00fczdeki birka\u00e7 y\u0131l i\u00e7inde piyasaya s\u00fcr\u00fclmesi hedefleniyor. E\u011fer bu teknoloji ba\u015far\u0131l\u0131 olursa, sadece pandeminin g\u00fcm\u00fc\u015f astar\u0131 olmakla kalmay\u0131p, ayn\u0131 zamanda t\u0131pta ve kanser tedavisinde yeni bir \u00e7a\u011f ba\u015flatabilir.<\/figcaption><\/figure>\n<\/section>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.ntv.com.tr\/galeri\/ntvpara\/tekno-finans\/kanserde-mucadelede-yeni-gelisme-covid-asilarindan-ilham-alindi,gPnr7yQw5UyCsYSBSMRP0w\"><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>COVID-19 pandemisinin en \u00f6nemli teknolojik kazan\u0131mlar\u0131ndan biri olan mRNA a\u015f\u0131lar\u0131, \u015fimdi de kanserle m\u00fccadelede devrim yaratma potansiyeliyle g\u00fcndemde. COVID-19 a\u015f\u0131lar\u0131yla d\u00fcnyan\u0131n dikkatini \u00e7eken bu teknoloji, ba\u011f\u0131\u015f\u0131kl\u0131k sistemini e\u011fiterek hastal\u0131klarla daha etkili bir \u015fekilde sava\u015fmay\u0131 m\u00fcmk\u00fcn k\u0131l\u0131yor. mRNA kanser a\u015f\u0131lar\u0131, v\u00fccudun ba\u011f\u0131\u015f\u0131kl\u0131k sistemine belirli kanser t\u00fcrlerini hedef alma ve yok etme &#8220;talimatlar\u0131n\u0131&#8221; veriyor. Bu a\u015f\u0131lar, hastan\u0131n [&hellip;]<\/p>\n","protected":false},"author":908,"featured_media":20019,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[12],"tags":[],"class_list":["post-20018","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-teknoloji"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/kibrisayna.com\/wp-content\/uploads\/2025\/03\/9pVZgAkOdU-NYafhpvSvPA.jpg","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/kibrisayna.com\/index.php\/wp-json\/wp\/v2\/posts\/20018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kibrisayna.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kibrisayna.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kibrisayna.com\/index.php\/wp-json\/wp\/v2\/users\/908"}],"replies":[{"embeddable":true,"href":"https:\/\/kibrisayna.com\/index.php\/wp-json\/wp\/v2\/comments?post=20018"}],"version-history":[{"count":0,"href":"https:\/\/kibrisayna.com\/index.php\/wp-json\/wp\/v2\/posts\/20018\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kibrisayna.com\/index.php\/wp-json\/wp\/v2\/media\/20019"}],"wp:attachment":[{"href":"https:\/\/kibrisayna.com\/index.php\/wp-json\/wp\/v2\/media?parent=20018"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kibrisayna.com\/index.php\/wp-json\/wp\/v2\/categories?post=20018"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kibrisayna.com\/index.php\/wp-json\/wp\/v2\/tags?post=20018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}